This 4.75" by 4.75"-sized magnet helps publicize the new 988 Suicide & Crisis Lifeline phone number and provides access to this life-saving resource in places that are highly visible.

The Safety Plan is a 5”x7” pad, similar to a prescription pad, with 50 sheets of pull off plans. The intended use is for counselors, therapists, clinicians, and others working with people in need of safety plans. It is modified from Stanley & Brown.

This cellphone-shaped magnet (size 3.25"x6") helps publicize the new 988 Suicide & Crisis Lifeline phone number and provides access to this life-saving resource in places that are highly visible.

An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3) the identification of drugs new to DAWN’s Drug Reference Vocabulary.

This document provides an overview of essential information necessary for understanding mental health and substance use disorder parity and how to implement and comply with federal parity laws. This guide applies to parity laws in employer-sponsored health plans and group and individual insurance.

This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.

The guide provides considerations and strategies for interdisciplinary teams, peer specialists, clinicians, registered nurses, behavioral health organizations, and policy makers in understanding, selecting, and implementing evidence-based interventions that support older adults with serious mental illness.

This updated TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence.